Peroxisome proliferator-activated receptor-gamma is a new therapeutic target in sepsis and inflammation

Basilia Zingarelli1, James A Cook

  • 1Division of Critical Care Medicine, Cincinnati Children's Hospital Medical Center and the College of Medicine, University of Cincinnati, Cincinnati, Ohio 45229, USA. basilia.zingarelli@cchmc.org

Shock (Augusta, Ga.)
|April 19, 2005
PubMed

Insights

Peroxisome proliferator-activated receptor-gamma (PPARgamma) ligands, like thiazolidinediones, show anti-inflammatory effects. These compounds offer potential therapeutic uses beyond diabetes for conditions such as sepsis and reperfusion injury.

Area of Science:

  • Molecular Biology
  • Endocrinology
  • Pharmacology

Background:

  • Peroxisome proliferator-activated receptor-gamma (PPARgamma) is a nuclear receptor regulating lipid metabolism, inflammation, and cell proliferation.
  • PPARgamma forms heterodimers with retinoid X receptor, binding DNA to modulate gene transcription upon ligand activation.
  • Thiazolidinediones are synthetic PPARgamma agonists used to study its gene regulation.

Purpose of the Study:

  • To provide an overview of PPARgamma's role in inflammatory response regulation.
  • To highlight the therapeutic potential of PPARgamma ligands beyond diabetes treatment.

Main Methods:

  • Review of in vitro and in vivo studies on PPARgamma activation.
  • Characterization of genes regulated by PPARgamma using thiazolidinediones.
  • Identification of natural ligands like J2 series cyclopentenone prostaglandins.

Main Results:

  • Pharmacological activation of PPARgamma by 15-deoxy-Delta(12,14)-PGJ2 or thiazolidinediones demonstrates anti-inflammatory effects.
  • PPARgamma plays a key role in modulating inflammatory pathways.
  • Synthetic and natural ligands effectively activate PPARgamma.

Conclusions:

  • PPARgamma ligands exhibit significant anti-inflammatory properties.
  • PPARgamma agonists represent promising therapeutic strategies for inflammatory diseases.
  • Potential applications include sepsis, inflammation, and reperfusion injury beyond glycemic control.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Peroxisomes01:24

Peroxisomes

Peroxisomes are specialized organelles present in fungi, plant, and animal cells. It can vary in number, size, morphology, and activity depending on the type of tissue and the nutritional state of the cell. For example, cells with active lipid metabolism, such as adipocytes, neurons, and hepatocytes, have more peroxisomes than other cells in the body. Besides their primary role in breaking down complex organic molecules, peroxisomes can also synthesize specific macromolecules and participate in...
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include: